Abbott Laboratories ABT · USD
Health Care · Health Care Equipment & Supplies · US listing · 🇺🇸 United States
S&P 500
110.51
+0.53%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Abbott Laboratories
From its filings with the US Securities and Exchange Commission
Abbott Laboratories is based in Abbott Park, Illinois and is incorporated in Illinois. Its shares trade on NYSE under the ticker ABT. It is a member of the S&P 500. The SEC classifies its business as pharmaceutical preparations. In the fiscal year to 31 December 2025, it reported revenue of $44.33bn and net income of $6.52bn. At that date it held total assets of $86.71bn and shareholders' equity of $52.13bn.
Abbott Laboratories is an Illinois corporation, incorporated in 1900. Abbott’s* principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products.
On November 19, 2025, Abbott entered into a definitive agreement to acquire Exact Sciences Corporation (Exact Sciences), which is expected to enable Abbott to enter the cancer diagnostics market. The acquisition is subject to customary closing conditions, including the approval of Exact Sciences shareholders and obtaining the required regulatory clearances.
Abbott has four reportable segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.
These products include a broad line of branded generic pharmaceuticals manufactured worldwide and marketed and sold outside the United States in emerging markets. These products are generally sold directly to wholesalers, distributors, government agencies, healthcare facilities, pharmacies, and independent retailers from Abbott-owned distribution centers or public warehouses, depending on the market served. Certain products are co-marketed or co-promoted with, or licensed from, other companies.
Quoted from its 10-K, filed 20 Feb 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 1 Mar 1937
- Employees
- 115,000
- Website
- abbott.com ↗
- Head office
- 100 ABBOTT PARK ROAD, ABBOTT PARK, IL, 60064-3500
- Incorporated in
- IL
- Classification
- Pharmaceutical Preparations
- Filer status
- Large accelerated filer
Leadership
Pay as last reported
- Mr. Robert FordChairman of the Board, Chief Executive Officer, since 2014$22.8m
- Mr. Philip BoudreauChief Financial Officer, Executive Vice President - Finance$8.2m
- Mr. Hubert AllenExecutive Vice President, General Counsel, Secretary$8.0m
- Ms. Mary MorelandExecutive Vice President - Human Resources
- Ms. Lisa EarnhardtExecutive Vice President, Group President - Medical Devices$6.6m
- Mr. Louis MorroneExecutive Vice President - Core Diagnostics
- Mr. Daniel SalvadoriExecutive Vice President, Group President - Established Pharmaceuticals and Nutritional Products$5.8m
- Ms. Andrea WainerExecutive Vice President - Rapid and Molecular Diagnostics$6.3m
- Mr. Randel WoodgriftSenior Vice President - Cardio Rhythm Management
- Mr. John MccoyVice President - Finance, Controller
- Ms. Nancy MckinstryLead Independent Director$395,892
- Ms. Nita AhujaDirector
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 80
- Environment
- 75
- Social
- 82
- Governance
- 82
- Direct emissions (scope 1)
- 510,000 t
- Energy emissions (scope 2)
- 471,000 t
- Value chain emissions (scope 3)
- 10,665,000 t
- Women in the workforce
- 46%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Abbott Laboratories possesses several key strengths that contribute to its success in the healthcare industry. These include:
Weaknesses
- Despite its strengths, Abbott Laboratories is also faced with certain weaknesses that could hinder its performance. These weaknesses include:
Opportunities
- Abbott Laboratories can explore various opportunities to further enhance its market position and growth potential, such as:
Threats
- Abbott Laboratories needs to be aware of the following threats that could potentially impact its business negatively:
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.